EE339 Cost Benefits of Midazolam Ready-to-Use Solution Versus IV Drugs in Local Anesthesia

Abstract

Demonstrate the cost benefits of the ready-to-use solution of midazolam (MRTU). According to the literature review, the failure caused by administrating drug errors represents 34,8% of adverse events in the hospital environment. Therefore, the ready-to-use solution could be an alternative to minimize the risks and errors.